Registered entities
Mito Immune Therapeutics Co., Ltd.
Reg. No. 350-87-01166South Korea
Innovation
14 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 294 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 10 |
| 2025 | 10 |
Investor mix
7 investors on record; lead investors include K-Ground.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Other / undisclosed | 2 | 29% |